Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab biosimilars


Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules

Read the original:
Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab biosimilars

Related Posts